My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 746 / https://doi.org/10.3332/ecancer.2017.746

Special Issue

The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

Cancer is one of the oldest diseases ever described, since ancient Egypt there have always been attempts to treat and cure this illness. The growing body of knowledge about breast cancer biology and improvements in surgical and medical treatments has been built over time with contributions from many talented and enthusiastic physicians and researchers. Medical advances have changed the approach from a previously incurable condition, into a surgical disease. Further improvements in cancer biology have allowed the development of systemic treatments, hormonal therapies, and targeted drugs. The description of the molecular intrinsic subtypes of breast cancer clarified the understanding of breast cancer as a group of heterogeneous diseases, associated with different clinical outcomes, and therapeutic opportunities. This paper reviews how breast cancer treatment has improved since the earliest descriptions, in ancient times, and how future approaches, such as gene signatures, molecular profiling, and liquid biopsies, aim to further develop individualised treatments and improve treatment outcomes.

Keywords: breast cancer, cancer history, breast surgery, gene signature, molecular profiling, liquid biopsy

Loading Article Metrics ... Please wait

Author interviews

Felipe Ades

Hospital Israelita Albert Einstein, São Paulo, Brazil

Related articles

Research: Frozen section evaluation of sentinel lymph nodes in breast carcinoma: a retrospective analysis

Abstract | Full Article | PDF Published: 18 Oct 2017 / https://doi.org/10.3332/ecancer.2017.774

Research: A discrete transition zone between cuticle and cortex layers of a human hair fibre: changes observed in the presence of breast cancer

Abstract | Full Article | PDF Published: 13 Oct 2017 / https://doi.org/10.3332/ecancer.2017.772

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Abstract | Full Article | PDF Published: 27 Sep 2017 / https://doi.org/10.3332/ecancer.2017.770

Research: Limitations of workers diagnosed with cancer evaluated with Work Role Functioning Questionnaire-Br

Abstract | Full Article | PDF | Portuguese Published: 18 Sep 2017 / https://doi.org/10.3332/ecancer.2017.769

Review: Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer

Abstract | Full Article | PDF Published: 18 Sep 2017 / https://doi.org/10.3332/ecancer.2017.768



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence